Efficacy and Safety Study of Pegylated Interferon Lambda-1a With Ribavirin and Daclatasvir, to Treat naïve Subjects With Chronic HCV Genotypes 1, 2, 3, and 4 Who Are Co-infected With HIV

PHASE3TerminatedINTERVENTIONAL
Enrollment

453

Participants

Timeline

Start Date

July 11, 2013

Primary Completion Date

August 27, 2015

Study Completion Date

August 27, 2015

Conditions
Chronic Hepatitis C Infection
Interventions
BIOLOGICAL

Pegylated Interferon Lambda-1a

DRUG

Daclatasvir (DCV)

DRUG

Ribasphere (RBV)

Trial Locations (63)

1000

Local Institution, Brussels

1119

Local Institution, Buenos Aires

1141

Local Institution, Buenos Aires, Bs As

1200

Local Institution, Brussels

1202

Local Institution, Buenos Aires

1878

Local Institution, Quilmes

2000

Local Institution, Antwerp

7600

Local Institution, Mar del Plata

13353

Local Institution, Berlin

14080

Local Institution, Mexico City

18102

Lehigh Valley Health Network, Allentown

20014

Local Institution, Donosti-San Sebastian

20052

Local Institution, Monza

20127

Local Institution, Milan

20146

Local Institution, Hamburg

21202

Mercy Medical Center, Baltimore

25123

Local Institution, Brescia

27710

Duke Clinical Research Institute, Durham

28034

Local Institution, Madrid

28041

Local Institution, Madrid

30202

Local Institution, Cartagena (Murcia)

30308

Emory Hospital Midtown Infectious Disease Clinic, Atlanta

Emory University, Atlanta

32803

Orlando Va Medical Center, Orlando

33604

Local Institution, Pessac

35350

Local Institution, Ciudad Juárez

37320

Local Institution, León

44280

Local Institution, Guadalajara

50011

Local Institution, Antella (fi)

53105

Local Institution, Bonn

53127

Local Institution, Bonn

69317

Local Institution, Lyon

75010

Local Institution, Paris

75020

Local Institution, Paris

75235

Ut Southwestern Medical Center, Dallas

80045

University Of Colorado Denver & Hospital, Aurora

University Of Colorado Denver, Aurora

92377

Inland Empire Liver Foundation, Rialto

94110

University Of California San Francisco, San Francisco

94118

Kaiser Permanente Medical Center, San Francisco

94275

Local Institution, Le Kremlin-Bicêtre

105275

Local Institution, Moscow

111123

Local Institution, Moscow

190103

Local Institution, Saint Petersburg

196645

Local Institution, Saint Petersburg

400040

Local Institution, Volgograd

06510

Yale University, New Haven

T6G 2B7

University Of Alberta Hospitals, Edmonton

V6Z 1Y6

St Pauls Hospital, Vancouver

V6Z 2C7

Vancouver Id Reserach & Care Centre Society, Vancouver

L8V 1C3

Hamilton Health Sciences, Mcmaster Site, Hamilton

K1H 8L6

Ottawa Hospital General Campus, Ottawa

Ottawa Hospital, Ottawa

H2X 2P4

Mcgill University Health Centre (Muhc) Montreal Chest Institute, Montreal

00149

Local Institution, Roma

91-347

Local Institution, Lodz

50-220

Local Institution, Wroclaw

08029

Local Institution, Barcelona

SW10 9TH

Local Institution, London

BN2 5BE

Local Institution, Brighton

E11BB

Local Institution, London

NW3 2QG

Local Institution, London

W2 1NY

Local Institution, London

Sponsors
All Listed Sponsors
lead

Bristol-Myers Squibb

INDUSTRY

NCT01866930 - Efficacy and Safety Study of Pegylated Interferon Lambda-1a With Ribavirin and Daclatasvir, to Treat naïve Subjects With Chronic HCV Genotypes 1, 2, 3, and 4 Who Are Co-infected With HIV | Biotech Hunter | Biotech Hunter